University of Lausanne Hospitals
chuv.chTotal trials
118
Active
7
Phase 3
2
Total enrollment
24,142
Read this sponsor's pipeline like an analyst.
Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.
~15-30 sec · cached for 24h
Pipeline matrix
Showing 1 of 1 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| 68Ga-NODAGA-RGD PET/CT | — | — | — | — | 2 |
Next readouts
- 2024-12
Top conditions
- Obesity4
- Stress4
- Nasal Obstruction3
- Knee Osteoarthritis3
- Coronary Artery Disease3
- Physical Activity3
- Prostate Cancer3
- Osteoarthritis, Knee2
Frequently asked questions about University of Lausanne Hospitals
- How many clinical trials does University of Lausanne Hospitals have on ClinicalTrials.gov?
- University of Lausanne Hospitals is listed as the lead sponsor on 118 clinical trials in ClinicalTrials.gov, 7 of which are currently active (recruiting, enrolling, or ongoing).
- How many of University of Lausanne Hospitals's trials are in Phase 3?
- 2 of University of Lausanne Hospitals's trials are in Phase 3, spread across 1 active drug program.
- What therapeutic areas does University of Lausanne Hospitals focus on?
- University of Lausanne Hospitals's most-studied conditions on ClinicalTrials.gov are Obesity, Stress, Nasal Obstruction, Knee Osteoarthritis, Coronary Artery Disease.
- When are University of Lausanne Hospitals's next clinical trial readouts?
- University of Lausanne Hospitals has 1 upcoming primary-completion readout tracked here; the soonest is “Multimodal Imaging Assessment of the Inflammatory Atheromatous Plaque”, expected around 2024-12.